文献速递类风湿关节炎

抗瓜氨酸化前胶原C端蛋白酶增强子抗体(抗PCOLCE):血清阴性类风湿关节炎的潜在生物标志物

Anti-citrullinated procollagen C-endopeptidase enhancer antibody (anti-PCOLCE): a potential biomarker for seronegative rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

本研究通过免疫表位数据库和分子模拟分析解析PCOLCE的B细胞表位,在612份血清中检测抗瓜氨酸化PCOLCE271-284抗体(抗PCOLCE),评估其对类风湿关节炎(RA)尤其血清阴性RA的诊断价值;抗PCOLCE在RA中敏感性51.53%、特异性93.60%,在抗CCP阴性RA中阳性率40.00%,与抗CCP联用敏感性82.14%、特异性90.21%。

要点

  • 抗PCOLCE在RA血清中显著升高,敏感性51.53%、特异性93.60%。
  • 抗PCOLCE在抗CCP阴性RA中阳性率40.00%,在抗CCP和RF双阴性RA中阳性率36.46%。
  • 抗PCOLCE与抗CCP联用诊断RA敏感性82.14%、特异性90.21%。

核心结论

  • 抗PCOLCE可作为RA尤其是血清阴性RA的新型生物标志物。

研究设计与样本

  • 通过免疫表位数据库和分子模拟分析解析PCOLCE的B细胞表位,并在包括RA患者、健康对照和其他风湿病患者的总共612份血清样本中检测抗瓜氨酸化PCOLCE271-284抗体(抗PCOLCE)。

主要发现

  • 抗PCOLCE在RA血清中显著升高,敏感性51.53%、特异性93.60%。
  • 抗PCOLCE在抗CCP阴性RA中阳性率40.00%,在RF阴性RA中阳性率38.76%,在抗CCP和RF双阴性RA中阳性率36.46%。
  • 抗PCOLCE与抗CCP联用诊断RA敏感性82.14%、特异性90.21%。
  • 抗PCOLCE在炎症因子正常的RA患者和早期RA患者中也有良好诊断价值。
  • 抗PCOLCE与CRP、抗CCP和RF呈正相关。

关键数值与推荐

  • 抗PCOLCE诊断RA的敏感性为51.53%,特异性为93.60%。
  • 抗PCOLCE在抗CCP阴性RA中阳性率为40.00%,在RF阴性RA中阳性率为38.76%,在抗CCP和RF双阴性RA中阳性率为36.46%。
  • 抗PCOLCE联合抗CCP诊断RA的敏感性为82.14%,特异性为90.21%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Although with great advances, the biomarkers used in the diagnosis of rheumatoid arthritis (RA) are still challenging, especially in seronegative RA. Recently, procollagen C-endopeptidase enhancer (PCOLCE) was revealed as a potential autoantigen of seronegative RA by our group. This study aimed to further analyse the B-cell autoantigenic epitopses of PCOLCE and the diagnostic value of its antibody in seronegative RA. METHODS: The B-cell epitopes of PCOLCE were elucidated by the Immune Epitope Database and molecular mimicry analyses. The anti-citrullinated PCOLCE271-284 antibody (anti-PCOLCE) was tested in a total of 612 serum samples including RA patients, healthy controls and patients with other rheumatic diseases. The diagnostic value of anti-PCOLCE in RA, especially for seronegative RA, was evaluated by ROC curve, sensitivity and specificity. Anti-PCOLCE in combination with anti-CCP for RA diagnosis was also demonstrated. The correlations of anti-PCOLCE with RA patient features were further analysed. RESULTS: Anti-PCOLCE was significantly elevated in RA serums with a sensitivity of 51.53% and specificity of 93.60%. More importantly, anti-PCOLCE had a favorable diagnostic value in seronegative RA, revealing a positive rate of 40.00% in anti-CCP negative RA, 38.76% in RF negative RA and 36.46% in anti-CCP and RF negative RA. The combination of anti-PCOLCE with anti-CCP demonstrated a high sensitivity of 82.14% and specificity of 90.21%. Anti-PCOLCE also has good diagnostic value in RA patients with normal inflammatory factors and early RA. Moreover, anti-PCOLCE was positively correlated with CRP, anti-CCP and RF. CONCLUSION: Anti-PCOLCE could serve as a novel biomarker for RA, especially for seronegative RA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lin H, Xie Y, Wei X, et al. Anti-citrullinated procollagen C-endopeptidase enhancer antibody (anti-PCOLCE): a potential biomarker for seronegative rheumatoid arthritis. Rheumatology (Oxford). 2025. PMID: 39909491. doi:10.1093/rheumatology/keaf058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。